URODOXA

This brand name is authorized in South Africa

Active ingredients

The drug URODOXA contains one active pharmaceutical ingredient (API):

1 Doxazosin UNII NW1291F1W8 - DOXAZOSIN

Doxazosin is a potent and selective post-junctional alpha-1-adrenoceptor antagonist. This action results in a decrease in systemic blood pressure. Read about Doxazosin

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
URODOXA Tablet	Health Products Regulatory Authority (ZA)	MPI, Generic

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
C02CA04	Doxazosin	C Cardiovascular system → C02 Antihypertensives → C02C Antiadrenergic agents, peripherally acting → C02CA Alpha-adrenoreceptor antagonists
Discover more medicines within C02CA04

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: ZA	Health Products Regulatory Authority	Identifier(s): 45/7.1/0150, 45/7.1/0151, 45/7.1/0152, 45/7.1/0153